Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Insider Christoph

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Get Free Report) insider Christopher G. Hayes sold 33,789 shares of the stock in a transaction on Monday, July 24th. The stock was sold at an average price of $4.83, for a total transaction of $163,200.87. Following the transaction, the insider now directly owns 81,925 shares in the company, valued […]

Related Keywords

United States , Canada , Christopherg Hayes , , Verrica Pharmaceuticals Stock , Verrica Pharmaceuticals Inc , Verrica Pharmaceuticals , Manchester Capital Management , Tower Research Capital , Goldman Sachs Group Inc , Citigroup Inc , Securities Exchange Commission , Institutional Investors Weigh In On Verrica Pharmaceuticals , Cubist Systematic Strategies , Royal Bank , News Ratings For Verrica Pharmaceuticals Daily , Verrica Pharmaceuticals Company Profile , Needham Company , Nasdaq , Get Free Report , Exchange Commission , Research Capital , Systematic Strategies , Capital Management , Sachs Group , Pharmaceuticals Inc , Verrica Pharmaceuticals Daily , Nasdaq Vrca , Vrca , Medical , Insider Trading , Nsider Trades , Stocks ,